Publication Name	World Journal of Neurology
Manuscript ID	16808
Country	United States

Received	2015-01-29 21:03
Peer-Review Started	2015-01-30 19:24
To Make the First Decision	2015-04-27 15:32
Return for Revision	2015-04-30 08:37
Revised	2015-06-04 10:52
Second Decision	2015-07-06 08:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-07-17 14:27
Articles in Press	2015-07-17 14:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-22 22:13
Publish the Manuscript Online	2015-09-30 16:28

ISSN	2218-6212 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Neurosciences
Manuscript Type	Editorial
Article Title	Hypocretin (orexin) pathology in Alzheimer’s disease
Manuscript Source	Invited Manuscript
All Author List	Thomas C Thannickal
Funding Agency and Grant Number
Corresponding Author	Thomas C Thannickal, PhD, Associate Researcher, Veterans Administration Greater Los Angeles Healthcare System, Neurobiology Research (151A3), North Hills, 16111 Plummer St., CA 91343, United States. thomastc@ucla.edu
Key Words	Hypocretin; Orexin; Alzheimer’s disease; Neurological disorders
Core Tip	Hypocretin plays an important role in the control of sleep-wake cycle. Increased hypocretin levels in Alzheimer’s disease patients suggest hypocretin system is involved during development of the disease symptoms.
Publish Date	2015-09-30 16:28
Citation	Thannickal TC. Hypocretin (orexin) pathology in Alzheimer’s disease. World J Neurol 2015; 5(3): 64-67
URL	http://www.wjgnet.com/2218-6212/full/v5/i3/64.htm
DOI	http://dx.doi.org/10.5316/wjn.v5.i3.64

Full Article (PDF)	WJN-5-64.pdf
Full Article (Word)	WJN-5-64.doc
Manuscript File	16808-Review.docx
Answering Reviewers	16808-Answering reviewers.pdf
Audio Core Tip	16808-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	16808-Conflict-of-interest statement.pdf
Copyright License Agreement	16808-Copyright assignment.pdf
Peer-review Report	16808-Peer-review(s).pdf
Scientific Misconduct Check	16808-Scientific misconduct check.pdf
Scientific Editor Work List	16808-Scientific editor work list.pdf